Position in ALXO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,207,555
+$654,627 QoQ
Shares Held
1,101,025
-19.9% QoQ
Ownership
0.818%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 68 holders
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALXO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. ALXO ranks #42 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,900,824 | $178,905,554 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
151,191 | $116,816,214 | |
| 3 | LEGN |
Legend Biotech Corp
|
1,527,336 | $27,629,508 | |
| 4 | TBPH |
Theravance Biopharma, Inc.
|
1,276,576 | $20,718,828 | |
| 5 | RIGL |
Rigel Pharmaceuticals Inc
|
666,426 | $18,020,159 | |
| 6 | IMCR |
Immunocore Holdings plc
|
501,091 | $15,107,893 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
1,547,593 | $15,042,603 | |
| 8 | PBYI |
Puma Biotechnology, Inc.
|
2,041,759 | $13,046,840 |
All Filings in ALXO
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,207,555 | 1,101,025 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,552,928 | 1,374,273 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $2,234,109 | 1,220,825 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $526,219 | 1,267,999 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $807,614 | 1,296,331 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $1,852,778 | 1,109,448 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $776,091 | 426,424 | Shares | Defined | 2024-11-12 | |
| 2022-06-30 | $169,525 | 20,955 | Shares | Defined | 2022-08-09 | |
| No filing history on record for this holder in this stock. | ||||||